A study by the SOEG confirms that infection by SARS-CoV-2 increases obstetric morbidity and premature deliveries

A study by the SOEG confirms that infection by SARS-CoV-2 increases obstetric morbidity and premature deliveries

A study by the SOEG confirms that infection by SARS-CoV-2 increases obstetric morbidity and premature deliveries

Physiological changes caused by pregnancy have been shown to increase the risk that pregnant women infected with SARS-CoV-2 may develop obstetric complications. For this reason, a group of researchers that is part of the Spanish Obstetric Emergency Group (SOEG), including Dra. Pilar Prats of Dexeus Mujer, has carried out a large prospective study performed in more than 78 centres in order to compare obstetric and perinatal results in 1,347 pregnant women infected by COVID 19 with respect to a sample of 1607 SARS-CoV-2-negative pregnancies. SOEG has one of the largest registries of pregnant women infected by COVID 19 in the world. The study was carried out in the period of the first two waves with the highest incidence of infection in Spain, from 1st March to 5th May, and from 14th July to 5th November 2020. All procedures were approved by the Ethics Committee on medical and clinical research of the Puerta del Hierro University Hospital in Madrid.

Of the 1,347 positive pregnancies, 51.1% were asymptomatic at the time of delivery, while 48.9% had symptoms. Among symptomatic patients, 70.9% had mild or moderate symptoms, 25.2% had pneumonia, and 3.9% (complicated pneumonia / shock (with admission to the ICU and / or mechanical ventilation and / or septic shock). ikewise, between both groups differences were observed in premature rupture of membranes; venous thrombotic events and the incidence of severe pre-eclampsia, which could have been overestimated in the infected cohort due to shared laboratory signs between this hypertensive disorder and COVID-19.

The authors conclude that pregnant patients infected by SARS-CoV-2 are a population at risk of preterm deliveries, mainly due to iatrogenic deliveries in women with pneumonia and / or pre-eclampsia and indicate that it is urgent now to perform an in-depth analysis of the influence of SARS-CoV-2 infection on the development of pre-eclampsia, and the risk factors for admission to the ICU of pregnant women infected by SARS-CoV-2.

Reference article:

Pregnancy Outcomes and SARS-CoV-2 Infection: The Spanish Obstetric Emergency Group Study
Viruses. 2021 May 7;13(5):853. doi: 10.3390/v13050853.

¿Cómo podemos ayudarte?

Te informamos que los datos de carácter personal que proporciones rellenando el presente formulario serán tratados por Fundación Dexeus Mujer como responsable de esta web. La finalidad de la recogida y tratamiento de estos datos es contactar contigo en referencia a tu solicitud y en caso de que expresamente nos autorices enviarte información sobre actividades, promociones y/o servicios y nuestro boletín informativo periódico. La legitimación se realiza a través del consentimiento del interesado. Podrás ejercer tus derechos de acceso, rectificación, limitación y suprimir los datos ante el delegado de protección de datos en dpd@dexeus.com así como el derecho a presentar una reclamación ante una autoridad de control. Puedes consultar la información adicional y detallada sobre Protección de Datos en nuestra política de privacidad.

How can we help you?

We inform you that the personal data that you provide by filling in this form will be treated by Dexeus Mujer Foundation as responsible for this website. The purpose of collecting and processing this data is to contact you regarding your request and in the event that you expressly authorize us to send you information on activities, promotions and / or services and our periodic newsletter. The legitimation is carried out through the consent of the interested party. You can exercise your rights of access, rectification, limitation and delete the data before the data protection officer at dpd@dexeus.com as well as the right to file a claim with a control authority. You can consult the additional and detailed information on Data Protection in our privacy policy.